Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Explore which Has Lower Expense Ratio Index Fund Or Tdf to help minimize costs. This guide covers expense ratios, fund structure, and practical selection tips.
28,115 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Strategy transferred 411.48 BTC to Coinbase on May 29, 2026, a tiny slice of its huge stake. The move sparks renewed ...
As AI workloads surge, hyperscalers turn to ASICs to cut costs. This deep dive compares Broadcom and Marvell, explain...
ScrollTech earns Deloitte’s nod as the fastest-growing software firm in North America and launches a pre-IPO round ti...
Michael Saylor rebutted critics of MicroStrategy's Bitcoin sales as BTC slides and the stock falters. He stressed the...
At a White House ceremony on President Trump’s 80th birthday, trump-backed World Liberty Financial announced a USD1 s...
Investors are scrutinizing SpaceX's AI arm after Grok posted steep losses while debt plans and data-center leases res...
As BTC consolidates in 2026, Coinbase, BlackRock and Strategy emerge as the top on-chain holders. This report breaks ...
Strategy faces a tough trade-off: use cash to back STRC dividends and buy Bitcoin, or raise fresh capital that dilute...
Lucid has set a production target, but many investors wonder if the pace will match the plan. This deep dive explains...
A Nevada mom pulled off an audacious scam, selling fake creator trips and later faking cancer to cover it up. This ca...
XRP's leverage and open interest have tumbled, but ETF funds and Ripple's expansion keep money in the ecosystem. Trad...